NMPA Launches “Drug Standard Management Measures” to Enhance Drug Quality and Safety
The National Medical Products Administration (NMPA) has released the “Drug Standard Management Measures,” a set...
NMPA
Helio Genomics’ Sister Company LAMH Wins NMPA Approval for Liver Cancer Test in China
Helio Genomics has announced that its ‘sister company’ Laboratory for Advanced Medicine & Health Group...
Sino-Cuban JV Biotech Pharmaceutical Receives NMPA Approval for Nimotuzumab in Pancreatic Cancer
Sino-Cuban joint venture (JV) Biotech Pharmaceutical Limited (BPL) announced last week that it has received...
NMPA Issues Procedures for Enhancing Children’s Medication Information in Drug Inserts
The National Medical Products Administration (NMPA) has released the “Procedures for Adding Children’s Medication Information...
China’s NMPA and NHC Tighten Regulations on Tramadol Compound Preparations
The National Medical Products Administration (NMPA) and National Health Commission (NHC) have released a notification...
3SBio Inc. Initiates Phase III Clinical Study for Thrombopoietin in Chronic Liver Disease Patients
China-based 3SBio Inc. (HKG: 1530) has announced the enrollment of the first patient in a...
NMPA Releases 68th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 68th batch of reference drugs for...
China’s NHC and 13 Bureaus Launch Campaign to Rectify Pharmaceutical and Medical Services Practices
The National Health Commission (NHC) along with 13 other bureaus has jointly released a notification...
NMPA Releases 67th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 67th batch of reference drugs for...
NMPA Extends Public Feedback Period for ‘Drug Standardization Management Measures’ in China
The National Medical Products Administration (NMPA) in China has announced an extension to the public...
China’s Regulatory Bodies Unveil Guidelines to Strengthen Supervision of Medical Aesthetic Industry
The State Administration for Market Regulation, National Health Commission, National Administration of Traditional Chinese Medicine,...
NMPA Transitions Desloratadine, Loratadine, Ambroxol, and Naproxen to OTC Status
The National Medical Products Administration (NMPA) has indicated on its website that four products will...
NMPA Mandates Label Updates for 11 Drug Varieties Including Black Box Warnings
The National Medical Products Administration (NMPA) has released 10 notifications regarding revisions to package inserts...
NMPA’s 2022 Drug Supervision Report: Clinical Trials and Market Filings on the Rise
The National Medical Products Administration (NMPA) has released its “Annual Drug Supervision and Administration Statistics...
National Center Reports Increase in Medical Device Adverse Event Reports for 2022
The National Center for Adverse Event Monitoring has released its national annual report regarding the...
China’s NMPA, MPS, and NHC Announce Updates to Narcotics and Psychotropic Substances Catalog
The National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission have...
NMPA Introduces Procedures to Adjust Chemical Generic Reference Preparations
The National Medical Products Administration (NMPA) has released a document outlining procedures for the adjustment...
NMPA Releases 65th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 65th batch of reference drugs for...
CDE Issues Guidelines for Real-World Drug Research and Evidence Framework
The Center for Drug Evaluation (CDE) has released two important documents: the “Guiding Principles of...
China’s NMPA Releases 64th Batch of Reference Drugs for Generic Quality Consistency Evaluation
China’s National Medical Products Administration (NMPA) has released the 64th batch of reference drugs for...